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BACKGROUND: Diabetes mellitus (DM) is a heterogeneous group of disorders characterized by increasing blood glucose levels caused by 
insufficiency of insulin hormone production and activities. 
There are significant increases in DM case every year in 
Indonesia, as a consequent, alternative and better drug 
is needed to be developed. One of the plants that were 
often used as traditional medicine for DM in Indonesia 
was Muntingia carabula L. (kersen) leaf. The aim of this 
research was to evaluate the antidiabetes activity of M. 
carabula leaves. 
METHODS: This study was conducted in vivo by evaluating 
the  antidiabetic  activity  of  M. carabula  leaf  water 
extract on two animal models, those are insulin deficiency 
and insulin resistant model animal. The insulin deficiency 
animal model was developed by aloxan administration at 
dose of 50 mg/Kg body weight (bw) intravenously. While 
the insulin resistance animal model was developed by lipid 
emulsion administration at dose of 0.42 mL/20 grams bw 
orally. Both groups were randomly devided into 6 groups, 
which are negative control group, positive control group, 
standard drug group (glybenclamide 0.65 mg/Kg bw or 
metformin 135 mg/Kg bw), and extract groups at dose 
of 100, 200 and 400 mg/Kg bw. Parameters which were 
evaluated are fasting blood glucose (FBG) levels for insulin 
deficiency models and values of constant of insulin tolerance 
(KITT) for insulin resistant models.
RESULTS: In  insulin  deficient  model  group, 
administration of glibenclamide lower the FBG by 43%, 
furthermore,  the  extract  of  M. calabura  at  doses  of 
100, 200 and 400 mg/Kg bw also lower the FBG by 13%, 
22% and 29%, subsequently. In insulin resistant models, 
metformin increased the value of KITT from less than 0.5 to 
2.91, and administration of the extract at doses of 400, 200 
and 100 mg/Kg bw also increased the KITT value to 2.31, 
1.57, 1.13, respectively.
CONCLUSION: The conclusion was M. carabula 
leaves water extract with dose of 400 mg/Kg bw had the 
antidiabetic activities with mechanisms to lower blood 
glucose level, regenerate pancreatic β cells, and increase 
insulin sensitivity.
KEyWORDS: diabetes mellitus, kersen leaves, Muntingia 
calabura L., insulin deficiency, insulin resistance
Indones Biomed J. 2018; 10(2): 165-70 
Abstract
Introduction
Diabetes mellitus (DM) is a group of symptoms that arise 
due to an increase in blood glucose levels caused by 
decreasing in insulin secretion progressively.(1) These can 
be caused by decreasing in insulin secretion, decreasing 
in insulin sensitivity, or both.(2) The decreasing in insulin 
sensitivity or what is known as the insulin resistance is a 
condition when the target cell's ability to respond to insulin 
decreases. Thus recognized with hiperinsulinemia.(3) The 
prevalence of DM in Southeast Asia in 2014 was 8.3%, 
with undiagnosed cases of 52.8%.(4) Based on Indonesian 
Basic Health Research (RISKESDAS) data in 2007, the 
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prevalence of DM in Indonesia was as much as 5.7%.(5) 
Meanwhile, according to RISKESDAS data in 2013, the 
prevalence of DM in Indonesian population increased by 
6.8%. These data shows that DM has become a disease 
whose number of sufferers increasing within years.(6) 
 Type 2 DM (T2DM) is caused by various factors, 
including genetic and environmental factors. Genetic factors 
are associated with the ability of the pancreas to secrete 
insulin, while environmental factors are associated with 
obesity, overeating, lack of exercise, and stress, as well as 
aging. Impaired insulin secretion is a decreased ability of β 
cells in responding the glucose in the blood. This particular 
condition appears long before a T2DM development. 
Impaired  insulin  secretion  is  a  progressive  condition, 
and is strongly influenced by glucotoxicity and lipotoxicity. 
If not treated properly, it will cause mass destruction of 
pancreatic β cells. Insulin resistance is a condition which 
the insulin is not sufficiently produced proportionally in 
comparison with its blood concentration ratio. This is due 
to the insulin receptors impairment located in the liver and 
muscles.(7)
 Diabetics usually require regular monitoring to ensure 
that blood glucose levels remain in range of blood glucose 
target and minimize the occurrence of complications. Diet 
and physical activity are an important factor in managing 
DM, especially T2DM. In addition to lifestyle regulation, 
the oral antidiabetic drugs are also often used. Oral diabetes 
drugs consist of alpha-glucosidase inhibitors, biguanides, 
meglitinides, sulfonylureas, thiazolidinediones, and 
dipeptidyl peptidase 4 (DPP-4) inhibitors, a new group of 
oral antidiabetes.(8) 
 Treatment of DM until now is still symptomatic and 
should be done for a lifetime, thus potentially causing 
various side effects, such as hypoglycemic, headache, 
vomit, emesis, and symptoms in gastrointestinal.(9,10) 
Therefore it is necessary to explore the alternative treatment 
which can stabilize blood glucose level in normal range. 
Currently, plant is considered as a potential source of 
bioactive compounds. The secondary metabolite content in 
the plant has been known to have some activity. 
 Muntingia calabura L., locally known as kersen, 
traditionally has been used to control blood glucose level. 
Based on previous research, M. calabura leaves was known 
to contain flavonoid compounds, tannins, triterpenoids, 
saponins,  and  polyphenols  that  showed  antioxidant 
activity.(11) Antioxidants are substances that can inhibit 
or prevent damage or destruction due to oxidation.(12) 
Oxidative stress plays an important role in causing cell 
damage due to hyperglycemia. High blood glucose levels 
can stimulate the formation of free radicals.(13) Free 
radicals are compounds that have one or more unpaired 
electrons normally produced in cellular metabolism.(14,15) 
Oxidative stress occurs due to an imbalance between the 
number of free radical molecules and antioxidant compounds 
in the body. Oxidative stress can interfere with the cell's 
physiological processes, one of which is the islet cells in 
the pancreas as an insulin-secreting organ.  This is because 
pancreatic islet cells  have the least endogenous antioxidant 
levels  compared  to  other  cells.(13)  From  previous 
experiment, it was  known that M. calabura leaves water 
extract showed the antioxidant activity with total phenolic 
compound 2970.4 mg/100 grams galic acid.(11) According 
to this study, M. calabura leaves water extract was assumed 
to have potential antidiabetes effect. M. calabura leaves 
had also been shown to have antihyperglycemic activity 
in insulin deficiency animal model.(16) The aim of this 
research was to evaluate the activity of M. calabura leaves 
as an antidiabetes using two animal model, that was insulin 
deficiency and insulin resistance animal model.
Methods
Identification and Authentication of Plant Material
M. calabura leaves was obtained from Bumi Herbal, 
Bandung, Indonesia. Fresh plants were dried at 60-70°C and 
then grinded into small pieces. The plant identification and 
authentication was performed by Biological Department, 
Padjajaran University, Bandung, Indonesia.
Preparation of M. carabula Leaves Water Extract
1 Kg dried leaves of M. calabura was infused with 10 L 
aquades. The mixture was filtered using a filter paper and 
the filtrate was concentrated using freeze drier.(17) 
Animals
Male Swiss–Webster mice 2-3 months old weighing 20-
30 grams were kept at standard laboratory conditions at 
24-26°C, humidity 70-75%, and 12 hours light/dark cycle. 
Animals were fed with standard chow and water ad libitum. 
The methods in this study were performed in accordance 
with ethics and guide for animals care and used. Ethical 
approval was published by the Ethics Committee Padjajaran 
University with registration number 0218030380. The 
parameter measured in this experiment was fasting blood 
glucose level and histology of pancreas for insulin deficiency 
animal model and the value of constant of insulin tolerance 
test (KITT) for insulin resistance animal model.
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In vivo Antidiabetic Evaluation of M. calabura Leaves 
Extract in Insulin Deficiency Animal Model
There were two stages in antidiabetic testing in vivo, the first 
one was the induction phase and the second was the treatment 
phase. In the first phase, mice were induced with alloxan 
50 mg/Kg body weight (bw) intravenously.(18) Mice with 
hyperglycemia (blood glucose >200 mg/dL) will be used in 
the second phase of evaluation. Mice with hyperglycemia 
were randomly divided into 5 groups, which are positive 
control group, standard drug group (glybenclamide 0.65 
mg/Kg bw), and extract groups at dose of 100, 200 and 400 
mg/Kg bw, and the normal mice as a control negative group. 
Administration of extracts and glybenclamide as a standard 
drug were performed for 14 days. Parameters measured 
were blood glucose levels on days 3, 7, 11 and 14 during 
treatment. Mice blood was taken from the vein part of the 
tail and measured using EasyTouch® glucometer (Bioptik 
Technology, Miaoli, Taiwan). On the last day of evaluation, 
2 mice from each group were randomly selected to be 
sacrificed and pancreatic organ isolation was performed 
for histologic observation. The histologic examination was 
read by the researcher by comparing the gaps and size of 
Langerhans islet of each group qualitatively. The data 
obtained were then analyzed statistically using ANOVA 
method.
In vivo Antidiabetic Evaluation of M. calabura Leaves 
Extract in Insulin Resistance Animal Model
There were two stages in antidiabetic testing in vivo, the 
first one was the induction phase and the second was the 
treatment phase. In the first phase, mice were induced 
using lipid emulsion as written in the literature (19) with a 
modification at dose of 0.42 mL/20 grams bw for 2 weeks. 
After mice developed to insulin resistance condition, the 
experiment stepped to the second phase of evaluation. 
Mice with insulin resistance were randomly grouped into 
5 groups, which are positive control group, standard drug 
group (metformin 135 mg/Kg bw), and extract groups at dose 
of 100, 200 and 400 mg/Kg bw. Administration of extracts 
and metformin as a standard drug were performed for 14 
days. Parameters measured were insulin sensitivity before 
induction, after induction and after treatment using value 
of KITT. The data obtained were then analyzed statistically 
using ANOVA method.
Insulin Tolerance Test 
An insulin tolerance test (ITT) was performed using 
insulin 0.75 U/Kg bw, intraperitoneally. Blood glucose 
concentration from the tail vein was measured using the 
Easy Touch® blood glucosemeter at 0, 15, 30, 45 and 60 
minutes after insulin administration.(20) The data was made 
into graphical form and the gradient was calculated to obtain 
the value of KITT. Results
Figure  1  showed  that  intravenous  administration  of 
alloxan caused elevated blood glucose levels in mice (>200 
mg/dL).  The  negative  control group  had  the  relatively 
constant blood  glucose level compared to the alloxan-
induced group.
Figure 1. The elevation of blood glucose level upon aloxan 
administration. n for the negative control = 5 mice, n for the 
alloxan administered group = 25 mice.
Effects on Insulin Deficient Model
Table 1 and Figure 2 showed that all the treated group, 
either with glybenclamide as a standard drug or with M. 
calabura leaves extract, showed significant improvement 
in blood glucose level, compared with the positive control 
group. The glibenclamide group as a standard drug showed 
the largest decrease in fasting blood glucose level compared 
to the extract groups. 
Table 1. The percentage change in blood glucose level during 
treatment.
3 7 10 14
Negative control 2±9 -4±10 -2±7 -2±11
Positive control 4±5 5±7 7±7 10±7
Glibenclamide 0.65 mg/kg bw -8±2 -20±6 -34±6 -43±7
Kersen leaves extract 100 mg/kg bw -2±1 -6±3 -10±6 -13±9
Kersen leaves extract 200 mg/kg bw -3±2 -10±4 -18±8 -22±7
Kersen leaves extract 400 mg/kg bw -3±2 -12±3 -22±5 -29±4
Group
Blood Glucose Level Changes 
at Day- (%)
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Figure 2. The blood glucose level during 
treatment. KLWE=Kersen leaves water extract, 
p<0.05, n = 5 mice/group.
 From Table 1, we could see that the percentage decrease 
in blood glucose levels in the group given the extract was 
parallel to the administered dose. The higher the dose, the 
percentage decrease in blood glucose levels produced even 
greater. At the end of the experiment, blood glucose levels 
of glybenclamide group and extracts at dose of 100, 200 
and 400 mg/Kg bw group had not reached normal levels 
yet. Although all of the dosage groups of extracts had a 
statistically significant decrease in blood glucose levels 
compared with positive controls, but only doses of 400 mg/
Kg bw showed similar activity to the glybenclamide group. 
On the last day of the experiment, the mice were randomly 
sacrificed and pancreatic isolation was performed for 
histology with Hematoxylin-Eosin (HE) staining. Histology 
result was shown in Figure 3.
Effects on Insulin Resistant Model
Insulin resistant animal models was developed by 
administrating lipid emulsion (Lipofundin®) with a dose 
Negative control Positive control
Glibenclamide 
0.65 mg/kg bw
Kersen Leaves Extract
100 mg/kg bw
Kersen Leaves Extract
200 mg/kg bw
Kersen Leaves Extract
400 mg/kg bw
Figure 3. Histology of pancreas with HE staining. The circled 
area showed Langerhans islet. 
of 0.42 mL/20 grams bw. Parameters measured were the 
value of KITT at the time before induction, after induction, 
and after treatment. The value of KITT was shown in Table 2.Discussion
In vivo Antidiabetic Evaluation of M. calabura Leaves 
Extract in Insulin Deficiency Animal Model 
Figure 1 showed that intravenous administration of alloxan 
caused elevated blood glucose levels in mice (>200 mg/
dL). Alloxan is a derivate urea compound that causes 
hyperglycemia conditions by selectively destroying 
pancreatic β cells that produce insulin. The severity of 
pancreatic β cell damage is determined by the administered 
alloxan dose.(21). The alloxan toxic mechanism against 
pancreatic β cells is by oxidizing sulphydryl groups, 
inhibiting glucokinase enzymes, producing free radicals, 
and disrupting intracellular calcium homeostasis.(22,23,24) 
The selectivity of alloxan to pancreatic β cells is due to the 
similarity of structures with glucose which resulted in the 
mechanism of alloxan uptake by pancreatic β cells to be 
highly efficient.(25)
 Standard drug administration and extracts were 
performed for 14 days in hyperglycemic animals. Blood 
glucose levels as a parameter were measured at days 3, 7, 
10 and 14 treatment.  Figure 2 showed that all the treated 
group, either with glybenclamide as a standard drug or with 
M. calabura leaves extract, showed significant improvement 
in blood glucose level compared to positive control group. 
It was proved by the statistically differences of blood 
glucose level between the treated group (glybenclamide and 
extract administered groups) and positive control group at 
day 3, 7, 10, and 14 during treatment. The glybenclamide, 
as a standard drug, group showed the highest percentage 
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of decreased blood glucose levels compared to the other 
groups. The changes of blood glucose level during 
treatment compared to blood glucose level before treatment 
was presented as a percentage in Table 1. Glybenclamide 
has the ability to lower blood glucose levels by stimulating 
insulin secretion by pancreatic β cells.(8) Statistically, blood 
glucose level of all the extract groups at day 3, 7 and 10 
showed no significant difference compared to glibenclamide 
group; whereas at day 14, only the extract group at dose of 
200 mg/dL and 400 mg/dL showed no significant difference 
compared to glibenclamide group. It means that the extract 
at dose of 200 mg/dL and 400 mg/dL had the comparable 
activity with the glibenclamide as a standard drug.   
 On the last day of the experiment, the mice were 
sacrificed and pancreatic isolation was performed for 
histology with HE staining. HE staining allowed for 
qualitative observation of Langerhans islet. According to 
Figure 3, there was a significant difference between the 
Langerhan islet of the positive controls compared with the 
negative controls. On the negative control, the Langerhans 
islet looked full and there was no gap, whereas in the 
positive control group looked not full and there were many 
loopholes. This indicates the presence of pancreatic damage 
in animal-induced alloxan and animal modeling of insulin 
deficiency successfully performed. 
 While in the glybenclamide and extract group, 
the Langerhans islet looked fuller although there were 
still empty gaps. This indicated an improvement on the 
Langerhans islet due to treatment. Based on histological 
results, M. calabura leaves extract was thought to have the 
ability to prevent the disruption of Langerhan islet cells 
due to alloxan administration. There were still gaps in the 
histologic outcome possibly due to short experimental 
time. From Figure 3, we could see that the Langerhans 
islet condition in extract groups were parallel with the 
administered dose of the extract. The higher the dose, the 
fuller the Langerhans islet. From the animal model of insulin 
deficiency, it could be concluded that the water extract of M. 
calabura leaves at dose of 400 mg/Kg bw had antidiabetic 
activity, with the mechanism of regenerating pancreatic islet 
cells. In this study it was thought that antioxidant activity of 
the M. calabura leaves contribute to disrupt the diabetogenic 
action of the alloxan.
In vivo Antidiabetic Evaluation of M. calabura Leaves 
Extract in Insulin Resistance Animal Model
Table 2 showed that lipid emulsion administration with 
a dose of 0.42 mL/20 grams bw for 2 weeks could affect 
the KITT value. The induced group of mice experienced a 
significant decrease in KITT compared with the negative 
control group. Lower KITT  indicates lower insulin sensitivity. 
This data was supported by another study that showed  lipid 
administration could induce insulin resistance.(19) 
 After 2 weeks metformin or extract administration, the 
KITT was also measured. The result showed that metformin 
and extract administration could increase the KITT value. We 
could see that the KITT value in the group given the extract 
was parallel to the given dose. The higher the dose given, 
the higher KITT value produced. However, the groups that 
showed significantly different KITT values compared with 
the positive control group were the metformin group, the 
extract group with dose of 200 and 400 mg/Kg bw. But 
the group that had activity comparable to metformin as 
a standard drug was the extract group at dose of 400 mg/
Kg bw. These two groups showed no significant difference 
statistically. From this experiment, it was concluded that 
M. calabura leaves water extract could improve the insulin 
sensitivity in insulin resistance animal model.
 Based on phytochemical screening, it was known 
that M. calabura leaf extract contained flavonoid, tannins, 
triterpenoids, steroids and polyphenols compounds. 
Flavonoids were thought to decrease blood glucose levels 
by enhancing insulin secretion, reducing apoptosis and 
promoting proliferation of pancreatic β-cells, reducing 
insulin resistance, inflammation and oxidative stress in 
muscle and promoting translocation of Glucose transporter 
Group Before Induction
After 
Induction
14 Days After 
Treatment
Negative control 1.41±0.78 2.20±1.70* 2.00±0.56*
Positive control 1.83±0.33 0.18±0.20 0.25±0.15#
Metformin 135 mg/kg bw 1.61±0.48 0.21±0.33 2.91±1.15*
Kersen leaves extract 100 mg/kg bw 1.75±0.87 0.20±0.60 1.13±0.60#
Kersen leaves extract 200 mg/kg bw 2.00±0.56 0.09±0.14 1.57±0.71*#
Kersen leaves extract 400 mg/kg bw 1.48±0.51 0.14±0.18 2.31±1.21*
Table 2. The value of KITT during experiment.
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type 4 (GLUT4) via phosphatidylinositol-3-kinase (PI3K)/
Akt  and  AMP-activated  protein  kinase  (AMPK) 
pathways.(26) 
 The limitation of this study was the absence of 
measured insulin levels, so we could not determine whether 
there was a condition of hyperinsulinemia. Moreover, 
pancreatic staining performed only allowed qualitative 
histologic observation and could not specify the number of 
pancreatic β cells.
Conclusion
The conclusion from this experiment was that M. calabura 
leaves water extract with dose of 400 mg/Kg bw had the 
antidiabetic activity with mechanisms to increase insulin 
secretion, regenerate pancreatic β cells, and increase insulin 
sensitivity.
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